Statistics

Total Visits

Views
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 317

Total Visits per Month

November 2017 December 2017 January 2018 February 2018 March 2018 April 2018 May 2018
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 3 4 2 4 1 9 4

File Downloads

Views
dce-mri abstract.pdf 47

Top Country Views

Views
United States 67
Canada 62
France 46
United Kingdom 14
China 9
South Korea 9
Russia 9
Germany 7
Sweden 7
Netherlands 5

Top City Views

Views
Calgary 35
Miami Beach 23
Toronto 12
Ottawa 9
Nynäs 7
Santa Clara 6
Zhengzhou 6
Kansas City 5
Plano 4
Dundas 3